FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

GE Healthcare Class 1 Recall of Ventilator Safety Guard

FDA classifies as Class 1 a GE Healthcare recall of its CareScape R860 Inspiratory Safety Guard, a breathing accessory designed for use with the Cares...

Human Drugs

DBM Miracu PDO Suture Threads Cleared

FDA clears a DBM Corp. 510(k) for its Miracu PDO Suture Threads and its use on soft tissue approximation where absorbable sutures are appropriate.

Human Drugs

CGMP Deviations at Zhejiang Huahai

FDA warns Chinas Zhejiang Huahai Pharmaceutical Co. about significant CGMP deviations in its production of active pharmaceutical ingredients.

Medical Devices

Olympus Pays $85 Million for Failing to File Device Reports

Olympus Medical Systems and a former senior executive plead guilty to failing to file required adverse event reports involving its duodenoscopes and a...

Human Drugs

Indias Skylark CMC Refuses FDA Inspection

FDA warns Indias Skylark CMC over its refusal to permit agency inspectors to enter manufacturing areas and refusal to provide requested records.

Federal Register

FDA Meeting on Outsourcing Facilities Office Stock

Federal Register notice: FDA announces a 5/21 public meeting entitled FDAs Proposed Current Good Manufacturing Practice Policies for Outsourcing Facil...

Federal Register

Revised GMP Guide for Outsourcing Facilities

Federal Register notice: FDA makes available a revised draft guidance entitled Current Good Manufacturing Practice Guidance for Human Drug Compoundin...

Human Drugs

4 New Biosimilar Guidances

FDA commissioner Scott Gottlieb outlines provisions in four guidances to help advance the agencys Biosimilars Action Plan.

HHS Sued Over Trial Reporting Rule

Former FDAer Peter Lurie and journalism professor Charles Seife sue HHS, FDA, and NIH to overturn a final rule allowing some drug and medical device c...

Human Drugs

Biomarker Qualification Draft Guidance

FDA issues a draft guidance on the evidentiary framework it recommends for biomarker qualification under the 21st Century Cures Act.